SouthernTrader

Kommentare zu ausgewählten Aktien. Meine Meinung. Keine Handlungsempfehlung. Ua zu #Steinhoff #Nordex #Bayer #Moderna #BioNTech #Volkswagen #Micron #Wasserstoff

[Torsten Prochnow @TorstenProchnow]

Musk’s decision to decommission SpaceX’s Dragon spacecraft in response to Trump’s threat to cancel government contracts marks a dangerous escalation. This is no longer just a war of words; it is a direct challenge with real consequences for the nation’s space program and economic stability. The stakes could not be higher, and both men must recognize the gravity of this moment.

For years, @ElonMusk has driven innovation through SpaceX, reducing reliance on foreign space programs and advancing America’s position in the cosmos. Decommissioning Dragon jeopardizes critical missions, from satellite launches to ISS operations, and could set back progress by years.

Trump’s initial statement may have been a negotiating tactic, but it has triggered a reaction that could harm the country far more than either intended. This feud is spiraling out of control, and the Republican Party risks being caught in the crossfire as supporters grapple with divided loyalties.

The solution is clear: Musk and Trump need to speak directly and resolve this conflict. A phone call between the two could de-escalate tensions and prevent further damage.

Musk’s focus on long-term fiscal responsibility and Trump’s drive for immediate wins can coexist, but only if they find common ground. The country cannot afford to lose the contributions of either figure, nor can it withstand the chaos of their rivalry.

This is a pivotal moment. Both men have the power to shape the future, but their current path leads to mutual destruction. For the sake of national interests, they must set aside pride and work together.

The GOP, already strained by this rift, cannot endure a prolonged battle between its most influential voices. Cooler heads must prevail.

[SouthernTrader @trader_southern]

Some FOMO with $PLUG. Looks good.

[SouthernTrader @trader_southern]

@TigerLineTrades What about $PLUG? Nice move!

[SouthernTrader @trader_southern]

@itswooch https://t.co/9pf7D76R7N

[SouthernTrader @trader_southern]

All those who held Plug Power ( $PLUG ) since 2 January 2000 know what this dog is waiting for. Love the PP Panucci's Pizza anology. Thanks, @TheRoaringKitty!

[SouthernTrader @trader_southern]

Grok is not really sure about PP's share price on January 2, 2000, though. I'd be fine with $1.500 🚀 !

[SouthernTrader @trader_southern]

All those who held Plug Power ( $PLUG ) since 2 January 2000 know what this dog is waiting for. Love the PP Panucci's Pizza anology. Thanks, @TheRoaringKitty!

[Greg’s Dad @JCRollinthrough]

On January 2, 2000, financial markets were poised to reopen after the New Year’s holiday, with investors cautiously optimistic about the absence of significant Y2K-related disruptions. Analysts anticipated that relief over the smooth transition might lead to a positive market response. 

However, this optimism was short-lived. On January 4, 2000, the Nasdaq Composite experienced its largest single-day point drop at the time, falling 229.46 points (5.6%) to 3,901.69. The Dow Jones Industrial Average also suffered, declining 359.58 points (3.2%) to 10,997.93. These declines were attributed to growing concerns about potential interest rate hikes by the Federal Reserve to prevent the economy from overheating. 

This period marked the beginning of increased market volatility, leading up to the bursting of the dot-com bubble in the subsequent months.

[SouthernTrader @trader_southern]

@TheRoaringKitty All those who held Plug Power ( $PLUG ) since 2 January 2000 know what this dog is waiting for. Love the PP Panucci's Pizza anology. Thanks, @TheRoaringKitty!

[SouthernTrader @trader_southern]

Insane. Maybe only @TheRoaringKitty may save Plug Power ( $PLUG ) from short sellers.

[SouthernTrader @trader_southern]

@MikeWarren3 @PraxMs @devin_shinkle @gritstonebio @SECGov No, nothing, I am afraid. #Fraud seems to bee fine for the @SECGov.

[SouthernTrader @trader_southern]

The end is near. @gritstonebio ( $GRTS ) shares will be delisted from Nasdaq at the opening of business on October 22, 2024. This #fraud ends with a total loss for shareholders. I will sue #Gritstone and its leadership for this fraud. Who is with me? https://t.co/xuc34br1p9

[SouthernTrader @trader_southern]

@PraxMs @devin_shinkle @gritstonebio Would be great if @gritstonebio informed us about this. Delisting of $GRTS has taken place. Impossible to trade the shares since 21/10 market close. Shareholders were not informed about this. Is @SECGov aware of this fraud? https://t.co/1bNLpgCRCa

[SouthernTrader @trader_southern]

@devin_shinkle @gritstonebio Delisting concerns shareholders only. Investors will profit from the asset sale that is going to follow. I sincerely hope that there will be a class action against @gritstonebio's fraud. $GRTS

[SouthernTrader @trader_southern]

@PomerantzLLP Will there be a class action against @gritstonebio ( $GRTS ) for shareholders and where can I join this class action? This has been a massive fraud and those responsible should be put to justice.

[SouthernTrader @trader_southern]

@TradingCondor @gritstonebio https://t.co/dNcSVTEunA

[SouthernTrader @trader_southern]

They want to delist and then sell all the assets. Plein fraud, what @gritstonebio is doing, IMHO. It seems that they did not even try to find an investor buying the shares. Their market cap is 6 m. It was never cheaper to buy a listed biotech company with great IP.

[SouthernTrader @trader_southern]

They want to delist and then sell all the assets. Plein fraud, what @gritstonebio is doing, IMHO. It seems that they did not even try to find an investor buying the shares. Their market cap is 6 m. It was never cheaper to buy a listed biotech company with great IP.

[SouthernTrader @trader_southern]

@michaelbarck2 @MainzBioMed Die Bots scheint niemand zu bekämpfen, sie spammen einfach weiter. Dazu passt die abenteuerliche Kommunikation von Mainz Biomed, die eines börsennotierten Unternehmens unwürdig ist. Auf der Homepage weiterhin kein Hinweis auf das Scheitern des FDA-Antrags. https://t.co/FDlzrfDMfJ

[SouthernTrader @trader_southern]

@MainzBioMed "Encouraging feedback from the FDA" translates to a *failure* to receive a breakthrough device designation based on insufficient data. And a post late after market close and 2 weeks after the @US_FDA's decline is a slap into the face of your shareholders. https://t.co/Dft3BJF37j

[SouthernTrader @trader_southern]

@michaelbarck2 Nervt extrem. Man fragt sich, wer das steuert. Seriöse Infos findet man zu @MainzBioMed so auf Twitter nicht.

Und sehr merkwürdig, dass sie das Ergebnis ihres #FDA-Antrags nicht kommunizieren. Das ist eigentlich viel wichtiger. Hätte letzte Woche kommen müssen. #BioTech

[SouthernTrader @trader_southern]

@MainzBioMed "Encouraging feedback from the FDA" translates to a *failure* to receive a breakthrough device designation based on insufficient data. And a post late after market close and 2 weeks after the @US_FDA's decline is a slap into the face of your shareholders. https://t.co/Dft3BJF37j

[SouthernTrader @trader_southern]

Investors seem to understand that @MainzBioMed ( $MYNZ ) seems to haves failed to receive a Breakthrough Device Designation for its Next Gen CRC test by the @US_FDA. Still no public announcement from the company, though. We should find out soon.
Annoying spam on @X continues.

[SouthernTrader @trader_southern]

@MainzBioMed Great news, welcome Petra Smeltzer Starke!

Other question, though: Do you still intend to publish the #FDA's answer on your submission for a breakthrough device designation for the #CRC screening test? You should have received it 2 weeks ago. $MYNZ
https://t.co/Dft3BJF37j

[SouthernTrader @trader_southern]

Investors seem to understand that @MainzBioMed ( $MYNZ ) seems to haves failed to receive a Breakthrough Device Designation for its Next Gen CRC test by the @US_FDA. Still no public announcement from the company, though. We should find out soon.
Annoying spam on @X continues.

[SouthernTrader @trader_southern]

Erst #Aktionäre entschädigungsfrei enteignen, dann das von den lästigen Miteigentümern "befreite" Unternehmen mit hohem Profit verkaufen. Das ist kein Geschäftsmodell einer Autokratie, sondern nach der in 🇩🇪 im #StaRUG umgesetzten EU-#Restrukturierungsrichtlinie rechtlich "fein".

[Marc Tüngler @marc_tuengler]

… Danke, StaRUG!

Erst reißt sich Herr Pierer via StaRUG für kleines Geld die Leoni unter die Nägel, um seine Beute jetzt für großes Geld an die Chinesen zu veräußern.

Das offenbart erneut ungeschminkt, welch katastrophalen Schaden das StaRUG anrichtet.

https://t.co/anePZ4pOC0